These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3372039)

  • 1. Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus implication in virally induced allergy.
    Leibovitz E; Freihorst J; Piedra PA; Ogra PL
    Int Arch Allergy Appl Immunol; 1988; 86(1):112-6. PubMed ID: 3372039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of respiratory syncytial virus infection on the uptake of and immune response to other inhaled antigens.
    Freihorst J; Piedra PA; Okamoto Y; Ogra PL
    Proc Soc Exp Biol Med; 1988 Jun; 188(2):191-7. PubMed ID: 3375265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus protects against the subsequent development of Japanese cedar pollen-induced allergic responses.
    Liu B; Kimura Y
    J Med Virol; 2007 Oct; 79(10):1600-5. PubMed ID: 17705182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection.
    Anderson JJ; Norden J; Saunders D; Toms GL; Scott R
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1561-70. PubMed ID: 2197371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus.
    Kanesaki T; Murphy BR; Collins PL; Ogra PL
    J Virol; 1991 Feb; 65(2):657-63. PubMed ID: 1987374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus-specific IgE responses following infection: evidence for a predominantly mucosal response.
    Welliver RC; Sun M; Rinaldo D; Ogra PL
    Pediatr Res; 1985 May; 19(5):420-4. PubMed ID: 4000767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology.
    Sharma A; Wu W; Sung B; Huang J; Tsao T; Li X; Gomi R; Tsuji M; Worgall S
    J Virol; 2016 May; 90(10):5068-5074. PubMed ID: 26962219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus infection in anti-mu-treated mice.
    Graham BS; Bunton LA; Rowland J; Wright PF; Karzon DT
    J Virol; 1991 Sep; 65(9):4936-42. PubMed ID: 1908028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.
    Valosky J; Hishiki H; Zaoutis TE; Coffin SE
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):171-9. PubMed ID: 15643003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.
    Hu KF; Elvander M; Merza M; Akerblom L; Brandenburg A; Morein B
    Clin Exp Immunol; 1998 Aug; 113(2):235-43. PubMed ID: 9717973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to experimentally induced infection with respiratory syncytial virus: possible role in the development of pulmonary disease.
    Piedra PA; Camussi G; Ogra PL
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():325-33. PubMed ID: 2732693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus.
    Fisher RG; Crowe JE; Johnson TR; Tang YW; Graham BS
    J Infect Dis; 1999 Oct; 180(4):1324-7. PubMed ID: 10479165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
    Becker Y
    Virus Genes; 2006 Oct; 33(2):235-52. PubMed ID: 16972040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell redistribution kinetics after secondary infection of BALB/c mice with respiratory syncytial virus.
    Kimpen JL; Ogra PL
    Clin Exp Immunol; 1993 Jan; 91(1):78-82. PubMed ID: 8419089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.
    Sharma R; Woldehiwet Z
    Epidemiol Infect; 1992 Feb; 108(1):135-45. PubMed ID: 1547834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
    Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
    J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen.
    Saloga J; Renz H; Lack G; Bradley KL; Greenstein JL; Larsen G; Gelfand EW
    J Clin Invest; 1993 Jan; 91(1):133-40. PubMed ID: 8423213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.
    Wronski S; Dannenmaier J; Schild S; Macke O; Müller L; Burmeister Y; Seilheimer B; Müller M
    PLoS One; 2018; 13(4):e0195822. PubMed ID: 29672626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.